Download PDF
Thromb Haemost 1997; 78(02): 939-946
DOI: 10.1055/s-0038-1657656
Rapid Communication
Schattauer GmbH Stuttgart

Endothelium-derived Nitric Oxide Decreases Polymorphonuclear Leukocyte Interaction with the Deeply Injured Arterial Wall under Intermediate and High Shear Conditions

Patrick Provost
The Laboratory of Experimental Pathology, Montreal Heart Institute, and the University of Montreal Montreal Quebec, Canada
,
Yahye Merhi
The Laboratory of Experimental Pathology, Montreal Heart Institute, and the University of Montreal Montreal Quebec, Canada
› Author Affiliations
Further Information

Publication History

Received 06 1996

Accepted after resubmission 26 March 1997

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Previous studies have shown that nitric oxide (NO) inhibits specific agonist-induced polymorphonuclear leukocyte (neutrophil) and platelet aggregation in vitro. However, the inhibitory effects of NO on neutrophil interaction with the deeply injured arterial wall under conditions of flow is unknown. Therefore, we investigated the influence of NO derived from the endothelium on neutrophil and platelet interactions with the downstream arterial media under controlled flow conditions. Porcine aortic media, simulating deep arterial wall injury, was exposed to flowing porcine non-anticoagulated arterial blood for 5 min at intermediate (1006 s1) and high (3397 s1) shear conditions, and deposition of radiolabeled neutrophils and platelets was quantified. Neutrophil deposition on the exposed arterial media was reduced, by more than 30%, by pretreatment of the endothelium with the physiological precursor of NO, L-arginine, from 84.1 ± 13.7 to 57.4 ± 7.2 X 103/cm2 (p < 0.05) at 1006 s*1, and from 99.3 ± 9.8 to 65.5 ± 8.7 X KP/cm2 (p < 0.05) at 3397 s1 of shear rate, relative to control. Pretreatment of the endothelium with the inactive stereoisomer D-arginine had no effect on neutrophil deposition. These specific inhibitory effects of L-arginine were completely abolished by the inhibitor of NO synthesis, N^-nitro- L-arginine methyl ester (l-NAME) at both shear rates. Endothelial pretreatment with D-arginine, or with L-arginine, in the absence or presence of l-NAME, did not significantly influence platelet interaction with the thrombogenic arterial media at intermediate and high shear rates. These results indicate that NO derived from the endothelium can modulate and has a greater influence on neutrophil, than on platelet, interaction with the injured arterial wall exposing the media under conditions of flow typical to moderately and severely stenosed arteries.

 

  • References

  • 1 Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666
    CrossrefPubMedGoogle Scholar
  • 2 Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
    CrossrefPubMedGoogle Scholar
  • 3 Feelisch M, te PoelM, Zamora R, Deussen A, Moncada S. Understanding the controversy over the identity of EDRF. Nature 1994; 368: 62-65
    CrossrefPubMedGoogle Scholar
  • 4 Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 1116-1121
    CrossrefPubMedGoogle Scholar
  • 5 McCall T, Whittle BJR, Boughton-Smith NK, Moncada S. Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide. Br J Pharmacol 1988; 95: 517P
    PubMedGoogle Scholar
  • 6 Moilanen E, Vuorinen P, Kankaanranta H, Metsa-Ketela T, Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leukocyte functions. BrJ Pharmacol 1993; 109: 852-858
    CrossrefPubMedGoogle Scholar
  • 7 Riutta A, Alanko J, Mucha I, Vapaatalo H. Effects of Trolox C and SIN-1 on arachidonic acid metabolism and on cyclic GMP formation in leukocytes. Eur J Pharmacol 1994; 262: 217-222
    CrossrefPubMedGoogle Scholar
  • 8 Schröder H, Ney P, Woditsch I, Schrör K. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes. Eur J Pharmacol 1990; 182: 211-218
    CrossrefPubMedGoogle Scholar
  • 9 Sundqvist T, Forslung T, Bengtsson T, Axelsson KL. S-nitroso-N-acetyl- penicillamine reduces leukocyte adhesion to type I collagen. Inflammation 1994; 18: 625-631
    CrossrefPubMedGoogle Scholar
  • 10 Clancy R, Leszczynska J, Amin A, Levartovsky D, Abramson SB. Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerisation in human neutrophils. J Leukoc Biol 1995; 58: 196-202
    CrossrefPubMedGoogle Scholar
  • 11 Provost P, Lam JYT, Lacoste L, Merhi Y, Waters D. Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscler Thromb 1994; 14: 331-335
    CrossrefPubMedGoogle Scholar
  • 12 Merhi Y, Lam JYT, Lacoste L-L, Latour JG, Guidoin R, Waters D. Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces. Arterioscler Thromb 1993; 13: 951-957
    CrossrefPubMedGoogle Scholar
  • 13 Merhi Y, Guidoin R, Provost P, Leung T-K, Lam JYT. Increase of neutrophil adhesion and vasoconstriction with platelet deposition after deep arterial injury by angioplasty. Am Heart J 1995; 129: 445-451
    CrossrefPubMedGoogle Scholar
  • 14 Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. BrJ Pharmacol 1987; 92: 181-187
    CrossrefPubMedGoogle Scholar
  • 15 Radomski MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-646
    CrossrefPubMedGoogle Scholar
  • 16 Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90: 687-692
    CrossrefPubMedGoogle Scholar
  • 17 Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells. Microvasc Res 1975; 09: 335-344
    CrossrefPubMedGoogle Scholar
  • 18 Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB. Erythrocytes metabolically enhance collagen- induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 1991; 78: 154-162
    PubMedGoogle Scholar
  • 19 Bazzoni G, Dejana E, Del MaschioA. Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991; 76: 491-499
    PubMedGoogle Scholar
  • 20 Badimon L, Badimon J-J, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis 1986; 06: 312-320
    CrossrefPubMedGoogle Scholar
  • 21 Turitto VT, Baumgartner HR. Platelet-surface Interactions. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. J. B. Lippincott Company; Philadelphia, PA: 1982. pp 364-379
    Google Scholar
  • 22 Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752
    CrossrefPubMedGoogle Scholar
  • 23 Provost P, Merhi Y. BW755C, a dual lipoxygenase/cyclooxygenase inhibitor, reduces mural platelet and neutrophil deposition and vasoconstriction after angioplasty injury in pigs. J Pharmacol Exp Ther 1996; 77: 217-221
    PubMedGoogle Scholar
  • 24 Merhi Y, Provost P, Guidoin R, Latour J-G. Importance of platelets in neutrophil adhesion and vasoconstriction following arterial injury by angioplasty in pigs. Arterioscler Thromb Vase Biol. 1997 (in press)
    PubMedGoogle Scholar
  • 25 Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and hemostasis: basic principles and applications. Thromb Haemost 1986; 55: 415-435
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655
    CrossrefPubMedGoogle Scholar
  • 27 de GraafJC, Banga JD, Moncada S, Palmer RMJ, de GrootPG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284-2290
    CrossrefPubMedGoogle Scholar
  • 28 Hecker M, Mitchell JA, Harris HJ, Katsura M, Thiemermann C, Vane JR. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Comm 1990; 167: 1037-1043
    CrossrefPubMedGoogle Scholar
  • 29 Steele PM, Chesebro JH, Stanson AW, Holmes Jr DR, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-112
    CrossrefPubMedGoogle Scholar
  • 30 De ServiS, Mazzone A, Ricevuti G, Fioravanti A, Bramucci E, Angoli L, Stefano G, Specchia G. Granulocyte activation after coronary angioplasty in humans. Circulation 1990; 82: 140-146
    CrossrefPubMedGoogle Scholar
  • 31 Lundgren-Akerlund E, Olofsson AM, Berger E, Arfors KE. CDllb/CD18- dependent polymorphonuclear leukocyte interaction with matrix proteins in adhesion and migration. Scand J Immunol 1993; 37: 569-574
    CrossrefPubMedGoogle Scholar
  • 32 Garnotel R, Monboisse JC, Randoux A, Haye B, Borel JP. The binding of type I collagen to lymphocyte function-associated antigen (LFA) 1 integrin triggers the respiratory burst of human polymorphonuclear neutrophils. Role of calcium signaling and tyrosine phosphorylation of LFA-1. J Biol Chem 1995; 270: 27495-27503
    CrossrefPubMedGoogle Scholar
  • 33 Bohnsack JF, Zhou X-N. Divalent cation substitution reveals CD 18- and very late antigen-dependent pathways that mediate human neutrophil adherence to fibronectin. J Immunol 1992; 149: 1340-1347
    PubMedGoogle Scholar
  • 34 Bohnsack JF. CD ll/CD 18-independent neutrophil adherence to laminin is mediated by the integrin VLA-6. Blood 1992; 79: 1545-1552
    PubMedGoogle Scholar
  • 35 Nathan C, Srimal S, Farber C, Sanchez E, Kabbash L, Asch A, Gailit J, Wright SD. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix protein and CD ll/CD 18 integrins. J Cell Biol 1989; 109: 1341-1349
    CrossrefPubMedGoogle Scholar
  • 36 Merhi Y, Lacoste LL, Lam JYT. Neutrophil implications in platelet deposition and vasoconstriction after deep arterial injury by angioplasty in pigs. Circulation 1994; 90: 997-1002
    CrossrefPubMedGoogle Scholar
  • 37 Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu Y-M, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848-851
    CrossrefPubMedGoogle Scholar
  • 38 Yeo EL, Sheppard J-AI, Feuerstein IA. Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiological shear conditions (an injury vessel wall model). Blood 1994; 83: 2498-2507
    PubMedGoogle Scholar
  • 39 Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration accross activated, surface-adherent platelets via sequential action of P-selectin and the β2-integrin CD 1 lb/CD 18. Blood 1996; 88: 146-157
    PubMedGoogle Scholar
  • 40 Michelson AD, Benoit SE, Furman MI, Breckwoldt WL, Rohrer MJ, Barnard MR, Loscalzo J. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol 1996; 270: H1640-H1648
    PubMedGoogle Scholar
  • 41 Langford EJ, Wainwright RJ, Martin JF. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vase Biol 1996; 16: 51-55
    CrossrefPubMedGoogle Scholar
  • 42 Murohara T, Parkinson SJ, Waldman SA, Lefer AM. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets: role of protein kinase C. Arterioscler Thromb Vase Biol 1995; 15: 2068-2075
    CrossrefPubMedGoogle Scholar
  • 43 Forslund T, Sundqvist T. Nitric oxide reduces hydrogen peroxide production from human polymorphonuclear neutrophils. Eur J Clin Invest 1995; 25: 09-14
    CrossrefPubMedGoogle Scholar
  • 44 Provost P, Tremblay J, Merhi Y. The antiadhesive and antithrombotic effects of the nitric oxide donor SIN-1 are combined with a decreased vasoconstriction in a porcine model of balloon angioplasty. Arterioscler Thromb Vase Biol. 1997 (in press)
    PubMedGoogle Scholar
  • 45 Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel DJ, Valeri CR, Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an s-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89: 7674-7677
    CrossrefPubMedGoogle Scholar
  • 46 Myers PR, Minor Jr RL, Guerra Jr R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble s-nitrosocysteine than nitric oxide. Nature 1990; 345: 161-163
    CrossrefPubMedGoogle Scholar
  • 47 Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. s-Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992; 89: 444-448
    CrossrefPubMedGoogle Scholar
  • 48 Malinski T, Taha Z, Grunfeld S, Patton S, Kapturczak M, Tomboulian P. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem Biophys Res Commun 1993; 193: 1076-1082
    CrossrefPubMedGoogle Scholar
  • 49 Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 1986; 58: 783-789
    CrossrefPubMedGoogle Scholar
  • 50 Lefer AM, Ma X-l. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb 1993; 13: 771-776
    CrossrefPubMedGoogle Scholar
  • 51 Ma X-l, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993; 72: 403-412
    CrossrefPubMedGoogle Scholar
  • 52 Siegfried MR, Erhardt J, Rider T, Ma X-l, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 1992; 260: 668-675
    PubMedGoogle Scholar
  • 53 Lefer AM, Siegfried MR, Ma X-l. Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol 1993; 22 (Suppl. 07) S27-S33
    CrossrefPubMedGoogle Scholar
  • 54 Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995; 91: 1872-1885
    CrossrefPubMedGoogle Scholar
  • 55 Tsao PS, Ma X-l, Lefer AM. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J 1992; 123: 1464-1471
    CrossrefPubMedGoogle Scholar
  • 56 Nishida M, Kuzuya T, Hoshida S, Kim Y, Kitabatake A, Kamada T, Tada M. Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res 1990; 66: 253-258
    CrossrefPubMedGoogle Scholar
  • 57 Weiss SJ. Tissue destruction by neutrophils. N Eng J Med 1989; 320: 365-376
    CrossrefPubMedGoogle Scholar
  • 58 Groves PH, Penny WJ, Cheadle HA, Lewis MJ. Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty. Cardiovasc Res 1992; 26: 615-619
    CrossrefPubMedGoogle Scholar
  • 59 Groves PH, Lewis MJ, Cheadle HA, Penny WJ. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation 1993; 87: 590-597
    CrossrefPubMedGoogle Scholar
  • 60 Ovize M, de LorgerilM, Cathignol D, Delaye J, Renaud S. Inhibition of coronary artery thrombosis by SIN-1, a donor of nitric oxide. J Cardiovasc Pharmacol 1990; 16: 641-645
    CrossrefPubMedGoogle Scholar
  • 61 Darius H, Ahland B, Rucker W, Klaus W, Peskar BA, Schror K. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro-inhibition of 12-HPETE biosynthesis. J Cardiovasc Pharmacol 1984; 06: 115-121
    PubMedGoogle Scholar
  • 62 Bult H, Fret HRL, Herman AG. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation. J Cardiovasc Pharmacol 1989; 14 (Suppl. 11) S120-S123
    CrossrefPubMedGoogle Scholar
  • 63 Selak MA, Chignard M, Smith JB. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J 1988; 251: 293-299
    CrossrefPubMedGoogle Scholar
  • 64 Kornecki E, Ehrlich YH, De MarsDD, Lenox RH. Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase. J Clin Invest 1986; 77: 750-756
    CrossrefPubMedGoogle Scholar
  • 65 Handin RI, Karabin R, Boxer GJ. Enhancement of platelet function by superoxide anion. J Clin Invest 1977; 59: 959-965
    CrossrefPubMedGoogle Scholar
  • 66 Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990; 259: C697-C708
    CrossrefPubMedGoogle Scholar
  • 67 Wainwright CL, Martorana PA. Pirsidomine, a novel nitric oxide donor, suppresses ischemic arrythmias in anesthetized pigs. J Cardiovasc Pharmacol 1993; 22 (Suppl. 07) S44-S50
    PubMedGoogle Scholar
  • 68 Karlberg K-E, Chen J, Egberg N, Sylven C. SIN-1 partially and RGDS totally counteracts platelet aggregation as assessed in vitro by two independent whole blood methods. Thromb Res 1993; 72: 531-540
    CrossrefPubMedGoogle Scholar
  • 69 Groves PH, Banning AP, Penny WJ, Newby AC, Cheadle HA, Lewis MJ. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res 1995; 30: 87-96
    CrossrefPubMedGoogle Scholar
  • 70 Jen CJ, Mclntire LV. Characteristics of shear-induced aggregation in whole blood. J Lab Clin Med 1984; 103: 115-124
    PubMedGoogle Scholar
  • 71 Mruk JS, Chesebro JH, Webster MWI. Platelet aggregation and interaction with the coagulation system: implications for antithrombotic therapy in arterial thrombosis. Coron Artery Dis 1990; 01: 149-158
    CrossrefPubMedGoogle Scholar
  • 72 Radomski MW, Palmer RMJ, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193-5197
    CrossrefPubMedGoogle Scholar
  • 73 Lam JYT, Chesebro JH, Steele PM, Dewanjee MK, Badimon L, Fuster V. Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol 1986; 08: 1380-1386
    CrossrefPubMedGoogle Scholar
  • 74 Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70: 119-123
    Article in Thieme ConnectPubMedGoogle Scholar
  • 75 Maalej N, Folts JD. Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries. Circulation 1996; 93: 1201-1205
    CrossrefPubMedGoogle Scholar
  • 76 Nishikawa M, Kanamori M, Hidaka H. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites. J Pharmacol Exp Ther 1982; 220: 183-190
    PubMedGoogle Scholar